A Novel Digital Twin Strategy to Examine the Implications of Randomized Control Trials for Real-World Populations
View ORCID ProfilePhyllis M. Thangaraj, View ORCID ProfileSumukh Vasisht Shankar, Sicong Huang, Girish Nadkarni, View ORCID ProfileBobak Mortazavi, View ORCID ProfileEvangelos K. Oikonomou, View ORCID ProfileRohan Khera
doi: https://doi.org/10.1101/2024.03.25.24304868
Phyllis M. Thangaraj
1Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
Sumukh Vasisht Shankar
1Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
Sicong Huang
3Department of Computer Science and Engineering, Texas A&M University, College Station, TX
Girish Nadkarni
4The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
5The Division of Data Driven and Digital Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Bobak Mortazavi
3Department of Computer Science and Engineering, Texas A&M University, College Station, TX
Evangelos K. Oikonomou
1Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
Rohan Khera
1Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
2Section of Health Informatics, Department of Biostatistics, Yale School of Public Health, New Haven, CT
6Section of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, CT
7Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA
Data Availability
The SPRINT and ACCORD cohorts are publicly available through the National Heart, Lung, and Blood Institute Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). The Yale electronic health record cohorts are not available due to the use of patient data.
Posted March 26, 2024.
A Novel Digital Twin Strategy to Examine the Implications of Randomized Control Trials for Real-World Populations
Phyllis M. Thangaraj, Sumukh Vasisht Shankar, Sicong Huang, Girish Nadkarni, Bobak Mortazavi, Evangelos K. Oikonomou, Rohan Khera
medRxiv 2024.03.25.24304868; doi: https://doi.org/10.1101/2024.03.25.24304868
A Novel Digital Twin Strategy to Examine the Implications of Randomized Control Trials for Real-World Populations
Phyllis M. Thangaraj, Sumukh Vasisht Shankar, Sicong Huang, Girish Nadkarni, Bobak Mortazavi, Evangelos K. Oikonomou, Rohan Khera
medRxiv 2024.03.25.24304868; doi: https://doi.org/10.1101/2024.03.25.24304868
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2923)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12723)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4571)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2913)
- Health Policy (1069)
- Hematology (387)
- HIV/AIDS (924)
- Medical Education (423)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4341)
- Nursing (235)
- Nutrition (637)
- Oncology (2264)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6925)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (179)